Multiple Myeloma: Co-Chaired by Natalie S. Callander, MD and Parameswaran Hari, MD, MRCP

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of multiple myeloma.

Multiple Myeloma: Co-Chaired by Natalie S. Callander, MD and Parameswaran Hari, MD, MRCP

The live filming of this virtual event in our IPC series is now on-demand.

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of multiple myeloma.

Speakers:

  • Natalie S. Callander, MD | University of Wisconsin Carbone Cancer Center
  • Parameswaran Hari, MD, MRCP | Medical College of Wisconsin
  • Binod Dhakal, MD | Medical College of Wisconsin
  • Anita D’Souza, MD | Medical College of Wisconsin
  • Timothy M. Schmidt, MD | University of Wisconsin Carbone Cancer Center

Topics:

  • Frontline Therapy in Multiple Myeloma
  • R/R Multiple Myeloma
  • CAR-T Therapies in Multiple Myeloma
  • Amyloidosis
  • Bispecific Antibodies in Multiple Myeloma